Sun Pharmaceuticals has got approval from the Federal Trade Commission of the US to acquire Ranbaxy on condition that it sells its interest in generic minocycline tablets.
Under the proposed settlement, Ranbaxy’s generic minocycline capsule assets would be acquired by Torrent Pharmaceuticals that markets generic drugs in the US. In addition, Sun and Ranbaxy must supply generic minocycline tablets and capsules to Torrent until the company establishes its own manufacturing infrastructure.
Under the proposed settlement, Ranbaxy’s generic minocycline capsule assets would be acquired by Torrent Pharmaceuticals that markets generic drugs in the US. In addition, Sun and Ranbaxy must supply generic minocycline tablets and capsules to Torrent until the company establishes its own manufacturing infrastructure.
No comments:
Post a Comment